Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.

The Journal of infection - 1 Feb 2007

Sanchez Rosario, Portilla Joaquín, Gimeno Adelina, Boix Vicente, Llopis Coral, Sanchez-Paya Jose, Merino Esperanza, de la Sen Maria Luz, Muñoz Carlos, Reus Sergio, Plazas Joaquín

Abstract excerpt

OBJECTIVES: The aim was to evaluate the safety of short antiretroviral treatment interruptions and their virologic and immunologic consequences in HIV-infected adults on highly active antiretroviral treatment (HAART) with suppressed viral replication. The viral efficacy upon reintroduction was al...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Drug Administration Schedule

Share to Drug Therapy, Combination

Share to HIV Reverse Transcriptase

Share to Reverse Transcriptase Inhibitors

Share to Treatment Failure

Source

Identifiers

PMID: 16690132
DOI: 10.1016/j.jinf.2006.03.029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16690132-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.PMID 16690132Read ↗

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.Semantic proximity Read ↗

Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response.Semantic proximity Read ↗

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.Semantic proximity Read ↗

[Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results].Semantic proximity Read ↗

Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.Semantic proximity Read ↗

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy.Semantic proximity Read ↗

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure.Semantic proximity Read ↗

Determinants of HIV drug resistance mutations in plasma virus after treatment interruption.Semantic proximity Read ↗

HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count.Semantic proximity Read ↗

Drug resistance mutations during structured interruptions of HAART in two HIV-1-infected children.Semantic proximity Read ↗

HIV-1 natural viral suppressors: control of viral replication in the absence of therapySemantic proximity Read ↗

Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.